Jai Health plans heart disease biomarker test launch; Leicester Uni gets £7M biomarker investment;

> Indian company Jai Health is planning a launch of its genetic biomarker-based test to assess the risk of heart disease. Article

> The University of Leicester (U.K.) has received a £7 million ($11 million) donation to build a new biomarker facility. Press release | Article

> Genetic variants behind melanoma could affect how patients respond to Plexxikon and Roche's ($RHHBY) Zelboraf (vemurafenib). Press release | Abstract

> Chromosomal aberrations could point the way to personalized care, according to a review from the University of Colorado Cancer Center. Abstract | Blog post

> Plasma osteopontin marks prostate cancer aggression, risk and treatment response. Abstract

> Urine podocin:nephrin mRNA ratio could be a useful marker in kidney disease. Abstract

> Antigen Discovery gets a Phase II SBIR grant to find biomarkers linked with protection against malaria. Press release

> Researchers find three more diabetes markers. Article

> Boston diagnostics company Immunetics has received $629,000 in equity for the commercialization of a blood platelet contamination tester for hospitals and blood banks. Article

> Norwegian biotech and biopharma company BerGenBio has appointed former KuDOS CEO Barrie Ward to its board. Press release

And Finally… Speech patterns can be used as a marker for both depression severity and response to treatment, according to a U.S. and Australian research project. Abstract | Press release

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.